Help
Subscribe


All of GastroHep is now free access! - Click here to register Read For FREE - Our full range of review articles
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Guido Tytgat Profile of Pete Peterson Profile of Peter Cotton Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

Optimum bowel cleansing before colonoscopy

This month's issue of the American Journal of Gastroenterology examines a dual-action, low-volume bowel cleanser administered the day before colonoscopy.

News image

Optimal bowel preparation is vital for the efficacy and safety of colonoscopy.

The inconvenience, discomfort, required consumption of large volumes of product, and potential adverse effects associated with some bowel preparations deter patients from colonoscopy, and may provide inadequate cleansing.

A dual-action, non-phosphate, natural orange-flavored, low-volume preparation containing sodium picosulfate and magnesium citrate (P/MC) is being reviewed for bowel cleansing.

Dr Philip Katz and colleagues from Pennsylvania, USA reported that this was a phase 3, randomized, multicenter, assessor-blinded, prespecified non-inferiority, head-to-head study.

The team investigated the efficacy, safety, and tolerability of day-before administration of picosulfate and magnesium citrate vs 2L polyethylene glycol solution, and 2 5-mg bisacodyl tablets in adult patients preparing for colonoscopy.

The primary objective was to demonstrate the non-inferiority of picosulfate and magnesium citrate to 2L PEG-3350 and bisacodyl tablets in overall colon cleansing using a modified Aronchick scale.

The doctors also evaluated the efficacy in the ascending, mid, and recto-sigmoid segments of colon using a modified Ottawa scale.

Patient acceptability and tolerability of the bowel preparations were assessed via a standard questionnaire.

Adverse events related to the bowel preparation were reported by 1% of patients
American Journal of Gastroenterology

The research team assessed safety based on the monitoring of adverse events and meaningful findings on clinical evaluations including physical examinations, vital sign measurements, and electrocardiograms.

A total of 603 patients were randomized to receive either picosulfate and magnesium citrate or 2L PEG-3350 and bisacodyl tablets.

The team of doctors noted that based on the Aronchick scale, successful overall cleansing was similar in patients receiving picosulfate and magnesium citrate.

Patients receiving 2L PEG-3350 and bisacodyl tablets picosulfate and magnesium citrate demonstrated non-inferiority to 2L PEG-3350 and bisacodyl tablets in overall cleansing of the colon, as measured by the Aronchick scale.

Similarly, the efficacy of picosulfate and magnesium citrate , as measured by the Ottawa scale, was non-inferior to 2L PEG-3350 and bisacodyl tablets in cleansing the ascending, mid, and recto-sigmoid segments of the colon.

The researchers noted that patient-reported acceptability and tolerability for each item examined on the questionnaire was significantly greater for picosulfate and magnesium citrate compared with 2L PEG-3350 and bisacodyl tablets.

Treatment-emergent adverse events related to the bowel preparation reported by 1% of patients receiving picosulfate and magnesium citrate or 2L PEG-3350 and bisacodyl tablets were nausea, vomiting, and headache.

No clinically meaningful changes were noted in either treatment arm in data collected from physical examinations, vital sign measurements, and ECGs.

Dr Katz's team commented "When administered as a day-before dose, the bowel cleansing effects of picosulfate and magnesium citrate were non-inferior compared with 2L PEG-3350 and bisacodyl tablets using the clinician-rated Aronchick and Ottawa scales."

"Treatment acceptability was significantly more favorable in patients receiving picosulfate and magnesium citrate  than in patients receiving 2L PEG-3350 and bisacodyl tablets."

Am J Gastroenterol 2013; 108: 401409
20 March 2013

Go to top of page Email this page Email this page to a colleague

 03 September 2015

Advanced search
 03 September 2015 
Factors that influence GI transit with the wireless motility capsule
 03 September 2015 
Antibiotic resistance of H. pylori
 03 September 2015 
NAFLD in adolescents undergoing bariatric surgery
 02 September 2015 
Anxiety and functional dyspepsia
 02 September 2015 
Cancer predisposition genes in suspected Lynch syndrome
 02 September 2015 
Adherence to a gluten-free diet in celiac disease
 01 September 2015 
Nonceliac wheat sensitivity and autoimmune disease
 01 September 2015 
Dysphagia after antireflux surgery
 01 September 2015 
Predict treatment success in ulcerative colitis
 31 August 2015 

Fecal microbiota transplantation in IBD

 31 August 2015 
Probiotics and liver transplantation
 31 August 2015 
Cancer incidence in Barrett's
 28 August 2015 
Statin use and survival in pancreatic cancer
 28 August 2015 
Bacterial endotoxin and NAFLD
 28 August 2015 
Interferon-free regimens for Hep C
 27 August 2015 
HCV in Egypt
 27 August 2015 
Liver abnormalities in celiac disease
 27 August 2015 
Gene expression for hepatocellular carcinoma
 26 August 2015 
Medical management of diverticular disease
 26 August 2015 
Treatment of erosive esophagitis
 26 August 2015 
Dermatological complications of anti-TNF therapy in IBD
 25 August 2015 
Markers for colorectal cancer screening
 25 August 2015 
Long-term PPI use and serum gastrin levels
 25 August 2015 
Treatment for HCV and HIV-1 co-infection
 24 August 2015 
Treatment for HCV and HIV-1 co-infection
 24 August 2015 
Cirrhosis in Hepatitis C patients
 24 August 2015 
Aspirin use and colorectal cancer survival
 21 August 2015 
Activity indexes in ulcerative colitis
 21 August 2015 
Coffee and gallstone disease
 21 August 2015 
Alcoholic cirrhosis in relapse after liver transplant
 20 August 2015 
Cirrhosis in the USA
 20 August 2015 
Mortality causes in liver cirrhosis
 20 August 2015 
Risk of death in IBD
 19 August 2015 
Predicting intestinal surgery in Crohn's disease
 19 August 2015 
Sleep positioning device reduces reflux
 19 August 2015 
Improved screening colonoscopy quality
 18 August 2015 
Health insurance influences HCV screening outcomes
 18 August 2015 
Somatostatin analogues in polycystic liver disease
 18 August 2015 
Global consensus report on H. pylori gastritis
 17 August 2015 
Biomarker of fibrosis stage in NAFLD
 17 August 2015 
Prognostic score for primary biliary cirrhosis
 17 August 2015 
Measuring subjective health in patients with IBS
 14 August 2015 
Factors that influence ulcerative colitis procedure type
 14 August 2015 
H. pylori in African American and Hispanic veterans
 14 August 2015 
Hep E virus in decompensated chronic liver disease
 13 August 2015 
H. pylori in drinking water
 13 August 2015 
Sofosbuvir-regimens in HCV
 13 August 2015 
IBS among Japanese adolescents
 12 August 2015 
Infliximab in patients in IBD
 12 August 2015 
Predictors of severity of IBD
 12 August 2015 
Peritoneal carcinomatosis in colorectal cancer
 11 August 2015 
Chemotherapy and intestinal microbiomes
 11 August 2015 
H. pylori and immune thrombocytopenic purpura
 11 August 2015 
Sexual dysfunction after rectal cancer treatment
 10 August 2015 
Predicting lymph node metastasis in T1 colorectal cancer
 10 August 2015 
Scoring systems to predict alcoholic hepatitis outcomes
 10 August 2015 
Sofosbuvir-based regimens in veterans with HCV
 07 August 2015 
Factors associated with changes in ulcerative colitis
 07 August 2015 
Bariatric surgery and NASH in obese patients
 07 August 2015 
Caffeine and fibrosis in Hep C

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2015 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us